Efficacy and Safety of T-817MA in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD
Condition: Mild Cognitive Impairment Interventions: Drug: T-817MA; Drug: Placebo Sponsor: FUJIFILM Toyama Chemical Co., Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials